AGP Executive Report
Last update: an hour agoMozambique Drug Use Surge: Mozambique’s health facilities treated 17,783 people in the first half of 2026 for mental and behavioral disorders linked to drugs and other psychoactive substances—up 58.6% from the same period in 2025—showing the country is shifting from “transit” to local consumption. Public Health Support in Mozambique: Italy-backed projects in Beira boosted breast cancer prevention (“Pink October”), expanded HPV vaccination, strengthened telemedicine links for specialist care, and inaugurated a laboratory at Chingussura health center. Mental Health & Substance Harm: The drug-use report highlights that multiple substances and alcohol drive many cases, with Maputo leading and young adults (21–35) most affected—raising risks like depression and family breakdown. Health Research Spotlight (Tilapia): A University of Hawaiʻi study explains how Mozambique tilapia survive extreme salt stress, offering new clues for understanding stress biology. Regional Health Tech & Care Access: A new $1 antenatal testing bundle for HIV, syphilis, and hepatitis B flags Mozambique as a high-potential market for expanding screening through routine care.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
